RETATRUTIDE · RESEARCH FORMAT
Retatrutide Vial 10 mg
Lyophilised research vial with a stated 10 mg of Retatrutide for lawful laboratory analysis.
€69.90
Available to order10 mg
Add products to your basket without signing in. At checkout, verify your email with a secure link before placing an order. Open the link in the same browser to keep your basket.
DESCRIPTION
Clear identity for research procurement.
Lyophilised research vial with a stated 10 mg of Retatrutide for lawful laboratory analysis.
Retatrutide (LY3437943) is a synthetic peptide studied experimentally in relation to the GIPR, GLP-1R and GCGR receptors.
The lyophilised vial provides a discrete format for identity testing, material characterisation and development of validated laboratory procedures. No instructions for human administration are provided.
Retatrutide: compare all formats and prices →
Literature identity: LY3437943 · GIPR, GLP-1R and GCGR receptors. The source describes the molecule, not analytical certification of this particular lot. Coskun et al. (2022)
The name, stated strength, format and SKU are presented together so the order can be matched to receipt records and the declared analytical work.
- Molecule / composition
- Retatrutide
- SKU
- MOL-VIAL-RET-10
- Stated strength
- 10 mg
QUALITY & HANDLING
Statements follow the actual records.
We do not publish a generic purity percentage or storage instruction as a promise for every lot. Request available records and follow the information tied to the product received.
Analytical context
Method, sample, date and limitations should be evaluated together.
Traceability
Maintain linkage between order, receipt, material and documentation.
Research boundary
For lawful in-vitro, analytical and laboratory research use only. Not intended for human or veterinary use, consumption, diagnosis, treatment or disease prevention.
MORE PRODUCTS
Other available research formats.
SSL SECURITYDISPATCH FROM EUGREECE & CYPRUSEMAIL CONFIRMATION